semaglutide and dementia 1.7 million patients reveal stunning link between lower risk Study Shows Some Weight Loss

Semaglutide is a medication that belongs to a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs)

Single-nucleus RNA data preprocessing, clustering and annotation The raw gene expression matrix was filtered after removal of cells with either more than five mean absolute deviations more mitochondrial gene expression unique molecular identified counts, fewer than 500 detected genes or with more than 5 mean absolute deviations in total unique molecular identified counts

The glucagon component increases energy expenditure and fat oxidation, potentially addressing the metabolic adaptation problem from yet another angle

For the foundational science on the mechanisms these blends combine, see Healing & Recovery Peptides Explained